Drug intelligence / Profile preview

ornithine oxoglutarate

Development stage
Phase 1
Lead developer
Nicola Longo
Modality
Small Molecules
Administration
Oral
01

Overview

Ornithine oxoglutarate (OKG) is a salt formed by the combination of two molecules of L-ornithine and one molecule of alpha-ketoglutarate. It functions as an anaplerotic agent and nutritional supplement, primarily investigated for its ability to replenish intermediates of the citric acid (Krebs) cycle and support the urea cycle. In metabolic disorders such as propionic acidemia, OKG acts as a precursor to alpha-ketoglutarate, helping to bypass metabolic blocks, reduce hyperammonemia, and spare endogenous glutamine. Beyond its investigational use in rare metabolic diseases, OKG has been utilized to improve nutritional status and promote recovery in burn patients and children receiving total parenteral nutrition.

Brand names
CétornanOrnicetil
Other names
ornithine alpha-ketoglutarateornithine 2-oxoglutarateornithine2-oxoglutarateornithine-2-oxoglutarateL-ornithine L-alpha-ketoglutarate

Beyond the preview

Go deeper on ornithine oxoglutarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ornithine oxoglutarate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call